Inhibition by Interferon Preparations of a Solid Malignant Tumour and Pulmonary Metastasis in Mice
Overview
Authors
Affiliations
The perplexing role of immuno-oncology drugs in osteosarcoma.
Smrke A, Tam Y, Anderson P, Jones R, Huang P J Bone Oncol. 2021; 31:100400.
PMID: 34786332 PMC: 8577488. DOI: 10.1016/j.jbo.2021.100400.
Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer.
Molina-Arcas M, Moore C, Rana S, van Maldegem F, Mugarza E, Romero-Clavijo P Sci Transl Med. 2019; 11(510).
PMID: 31534020 PMC: 6764843. DOI: 10.1126/scitranslmed.aaw7999.
Cancer immunotherapy and nanomedicine.
Sheng W, Huang L Pharm Res. 2010; 28(2):200-14.
PMID: 20821040 DOI: 10.1007/s11095-010-0258-8.
Sangaletti S, Stoppacciaro A, Guiducci C, Torrisi M, Colombo M J Exp Med. 2003; 198(10):1475-85.
PMID: 14610043 PMC: 2194114. DOI: 10.1084/jem.20030202.
Accelerated tumor development in interferon-treated B6.C-Hyal-1 a mice.
De Maeyer-Guignard J, Lauret E, Eusebe L, De Maeyer E Proc Natl Acad Sci U S A. 1993; 90(12):5708-12.
PMID: 8516320 PMC: 46791. DOI: 10.1073/pnas.90.12.5708.